Insights

Platform Advantage Position Recursion OS and its massive proprietary biology and chemistry datasets as a premier AI driven discovery platform that external pharma and biotech partners can access to accelerate target discovery, hit generation, and lead optimization, supported by high throughput wet lab capabilities and industrial scale compute.

RBM39 Collaboration Capitalize on the ongoing REC-1245 DHALIA program by pursuing co development, biomarker discovery, and companion diagnostics partnerships with sponsors seeking to accelerate solid tumor programs.

Global Partnerships Leverage a global footprint to offer regional market access, regulatory navigation, and on the ground support for multinational pharma and CRO collaborations across discovery, development, and analytics.

Data Licensing Monetize proprietary biology and chemistry data assets and analytics capabilities through licensing or managed services agreements, enabling partners to reduce risk and accelerate early stage programs.

Competitive Positioning Differentiate from peers by combining AI powered biology with scalable experimentation and compute, enabling long term, milestone driven partnerships with large pharma, mid size biotech, and CROs.

Recursion Tech Stack

Recursion uses 8 technology products and services including iCIMS, html5media, Databricks, and more. Explore Recursion's tech stack below.

  • iCIMS
    Applicant Tracking Systems
  • html5media
    Audio, Video, Graphics
  • Databricks
    Big Data Processing
  • MinIO
    Enterprise Data Storage
  • SAML
    Identity And Access Management
  • Windows Server
    Operating Systems
  • Adobe Acrobat DC
    Rich Text Editors
  • Elasticsearch
    Search Engines

Media & News

Recursion's Email Address Formats

Recursion uses at least 2 format(s):
Recursion Email FormatsExamplePercentage
First.Last@recursionpharma.comJohn.Doe@recursionpharma.com
96%
First@recursionpharma.comJohn@recursionpharma.com
3%
First.L@recursionpharma.comJohn.D@recursionpharma.com
1%
First.Last@recursion.comJohn.Doe@recursion.com
80%
Last@recursion.comDoe@recursion.com
19%
First@recursion.comJohn@recursion.com
1%

Frequently Asked Questions

Where is Recursion's headquarters located?

Minus sign iconPlus sign icon
Recursion's main headquarters is located at 41 South Rio Grande Street Salt Lake City, Utah 84101 United States. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Recursion's phone number?

Minus sign iconPlus sign icon
You can contact Recursion's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Recursion's stock symbol?

Minus sign iconPlus sign icon
Recursion is a publicly traded company; the company's stock symbol is RXRX.

What is Recursion's official website and social media links?

Minus sign iconPlus sign icon
Recursion's official website is recursion.com and has social profiles on LinkedInCrunchbase.

What is Recursion's SIC code NAICS code?

Minus sign iconPlus sign icon
Recursion's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Recursion have currently?

Minus sign iconPlus sign icon
As of June 2026, Recursion has approximately 763 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Ceo: Y. J.Chief Communications Officer And Executive Leadership Team Member: R. K.Chief Scientific Officer: D. H.. Explore Recursion's employee directory with LeadIQ.

What industry does Recursion belong to?

Minus sign iconPlus sign icon
Recursion operates in the Biotechnology Research industry.

What technology does Recursion use?

Minus sign iconPlus sign icon
Recursion's tech stack includes iCIMShtml5mediaDatabricksMinIOSAMLWindows ServerAdobe Acrobat DCElasticsearch.

What is Recursion's email format?

Minus sign iconPlus sign icon
Recursion's email format typically follows the pattern of First.Last@recursionpharma.com. Find more Recursion email formats with LeadIQ.

How much funding has Recursion raised to date?

Minus sign iconPlus sign icon
As of June 2026, Recursion has raised $200M in funding. The last funding round occurred on Jun 26, 2024 for $200M.

When was Recursion founded?

Minus sign iconPlus sign icon
Recursion was founded in 2013.

Recursion

Biotechnology ResearchUtah, United States501-1000 Employees

Recursion is a clinical-stage biotechnology research company focused on decoding biology to radically improve lives. It operates the Recursion OS platform, which spans diverse technologies and builds one of the world's largest proprietary biological and chemical datasets. The company uses machine learning and AI to identify trillions of relationships across biology and chemistry, aiming to reduce human bias in interpretation. Recursion combines large-scale wet-lab experimentation—up to millions per week—with substantial computational power, including owning and operating a powerful supercomputer. Headquartered in Salt Lake City, Utah, at 41 South Rio Grande Street, with additional offices in Montréal, New York, London, and the Oxford area, Recursion has 501-1000 employees and trades on the NASDAQ under RXRX; more information is available at recursion.com.

Section iconCompany Overview

Headquarters
41 South Rio Grande Street Salt Lake City, Utah 84101 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RXRX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
501-1000

Section iconFunding & Financials

  • $200M

    Recursion has raised a total of $200M of funding over 18 rounds. Their latest funding round was raised on Jun 26, 2024 in the amount of $200M.

  • $25M$50M

    Recursion's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $200M

    Recursion has raised a total of $200M of funding over 18 rounds. Their latest funding round was raised on Jun 26, 2024 in the amount of $200M.

  • $25M$50M

    Recursion's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.